type 2 diabetes semaglutide 2·4 mg once a week in adults with overweight or obesity, and (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Oral Semaglutide GLP-1 for Type

Patients who are pregnant or planning to be, planning a major surgery, have a history of pancreatitis, thyroid medullary carcinoma, Multiple Endocrine Neoplasia Type 2, gallbladder disease or a history of gastroparesis should not be on these medications

Some compounded products use semaglutide salts, which differ chemically from the base form studied in FDA trials

The medication is self-administered as a subcutaneous injection in the stomach, thigh, or upper arm once a week on the same day every week

Structured meal planning is the most effective strategy for maximizing nutrition on reduced caloric intake

Symptoms of indigestion usually appear in the early stages of medication, and with the prolongation of medication time, most patients' symptoms will gradually improve

We monitor and adjust dosing to minimize side effects